Anxiolytic-and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR 149415, suggest an innovative approach for the treatment of stressrelated disorders - Griebel, G; Simiand, J; Serradeil-Le Gal, C; Wagnon, J; Pascal, M; Scatton, B; Maffrand, JP; Soubrié, P (Proc Natl Acad Sci USA, 2002)